deltatrials
Recruiting OBSERVATIONAL NCT05001477

Customized TULSA-PRO Ablation Registry (CARE)

Sponsor: Profound Medical Inc.

Conditions Benign Prostatic Hyperplasia Prostate Adenocarcinoma Prostate Cancer
Interventions TULSA Procedure
Updated 7 times since 2021 Last updated: Nov 5, 2024 Started: Oct 27, 2021 Primary completion: Oct 31, 2026 Completion: Oct 31, 2061
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Benign Prostatic Hyperplasia and Prostate Adenocarcinoma and is currently actively recruiting participants. Profound Medical Inc. leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Sep 2021 – ~May 2022 · 8 months · monthly snapshotRecruiting~May 2022 – ~Sep 2022 · 4 months · monthly snapshot~Sep 2022 – ~Dec 2023 · 15 months · monthly snapshotRecruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – present · 21 months · monthly snapshotRecruiting

Change History

7 versions recorded

  1. Dec 2024 — Present [monthly]

    Recruiting

  2. Sep 2024 — Dec 2024 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Dec 2023 — Jul 2024 [monthly]

    Recruiting

  5. Sep 2022 — Dec 2023 [monthly]

    Recruiting

▶ Show 2 earlier versions

  1. May 2022 — Sep 2022 [monthly]

    Recruiting

  2. Sep 2021 — May 2022 [monthly]

    Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Profound Medical Inc.
Data source: Profound Medical Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations